Health encyclopaedia - Alphabetical Topic List Gesundheits-Lexikon - Topic Alphabetische Liste

| A | | A | | B | | B | | C | | C | | D | | D | | E | | E | | F | | F | | G | | G | | H | | H | | I | | I | | J | | J | | K | | K | | L | | L | | M | | M |
| N | | N | | O | | O | | P | | P | | Q | | Q | | R | | R | | S | | S | | T | | T | | U | | U | | V | | V | | W | | W | | X | | X | | Y | | Y |

References of Alzheimer's disease Referenzen der Alzheimer-Krankheit

Further reading: Weiterführende Literatur:

Ginkgo does not enhance memory. Ginkgo nicht verbessern Speicher. NeLH report on clinical trail. NeLH Bericht über die klinische Strecke.

Memory and dementia. Memory und Demenz. Royal College of Psychiatrists. Royal College of Psychiatrists.

Guidance on the Use of Donepezil, Rivastigmine and Galantamine for the Treatment of Alzheimer's Disease. Leitlinien für die Verwendung von Donepezil, Galantamin und Rivastigmin für die Behandlung der Alzheimer-Krankheit. NICE. Nett.

Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. Klinische und Kosten-Nutzen-Verhältnisses von Donepezil, Galantamin und Rivastigmin bei der Alzheimer-Krankheit: eine schnelle und systematische Überprüfung. Clegg A et al. Clegg A et al. Health Technology Assessment 2001, volume 5, number 1. Health Technology Assessment 2001, Band 5, Nummer 1.

Dementia - diagnosis and treatment. Demenz - Diagnose und Behandlung. Bandolier 1998, issue 48, page 2. Bandolier 1998, Ausgabe 48, Seite 2.

The effect of different diagnostic criteria on the prevalence of dementia. Die Wirkung der verschiedenen diagnostischen Kriterien über die Prävalenz von Demenz. Erikinjuntti T et al. Erikinjuntti T et al. New England Journal of Medicine 1997, volume 337, pages 1667-74. New England Journal of Medicine 1997, Band 337, S. 1667-74.

Sources of variability in prevalence rates of Alzheimer's disease. Quellen der Variabilität der Prävalenz-Raten der Alzheimer-Krankheit. Corrada M et al. Corrada M et al. International Journal of Epidemiology 1995, volume 25, pages 1000-5. International Journal of Epidemiology 1995, volume 25, pages 1000-5.

Donepezil, Rivastigmine and Galantamine for the Treatment of Alzheimer's Disease. Donepezil, Galantamin und Rivastigmin für die Behandlung der Alzheimer-Krankheit. Technology Appraisal Guidance No 19. Technology Appraisal Guidance Nr. 19. 2001 2001

Galantamine for Alzheimer's disease (Cochrane Review). Galantamin für die Alzheimer-Krankheit (Cochrane Review). Olin J, Schneider L. The Cochrane Library, Issue 1, 2002. Olin J, Schneider L. The Cochrane Library, Issue 1, 2002.

Selegiline for Alzheimer's disease (Cochrane Review). Selegilin für Alzheimer's disease (Cochrane Review). Birks J, Flicker L. The Cochrane Library, Issue 1, 2002. Birks J, Flicker L. The Cochrane Library, Issue 1, 2002.

Donepezil for mild and moderate Alzheimer's disease (Cochrane Review). Donepezil für milde und moderate Alzheimer's disease (Cochrane Review). Birks JS et al. Birks JS et al. The Cochrane Library, Issue 1, 2002. The Cochrane Library, Issue 1, 2002.

Rivastigmine for Alzheimer's disease (Cochrane Review). Rivastigmin bei Alzheimer-Krankheit (Cochrane Review). Birks J et al, The Cochrane Library, Issue 1, 2002. Birks J et al, The Cochrane Library, Issue 1, 2002.

Thiamine for Alzheimer's disease (Cochrane Review). Thiamin für die Alzheimer-Krankheit (Cochrane Review). RodrÃguez-MartÃn JL et al. RodrÃguez-MartÃn JL et al. The Cochrane Library, Issue 1, 2002. The Cochrane Library, Issue 1, 2002.

Physostigmine for Alzheimer's disease (Cochrane Review). Physostigmin für Alzheimer's disease (Cochrane Review). Coelho Filho JM, Birks J. The Cochrane Library, Issue 1, 2002. Coelho Filho JM, Birks J. The Cochrane Library, Issue 1, 2002.

Efficacy and safety of Nicotine on Alzheimer's disease patients (Cochrane Review). Die Wirksamkeit und Sicherheit von Nikotin auf Alzheimer-Patienten (Cochrane Review). López-Arrieta JM et al. Là ³ PEZ-Arrieta JM et al. The Cochrane Library, Issue 1, 2002. The Cochrane Library, Issue 1, 2002.

Vitamin E for Alzheimer's disease (Cochrane Review). Vitamin E für die Alzheimer-Krankheit (Cochrane Review). Tabet N et al. Tabet N et al. The Cochrane Library, Issue 1, 2002. The Cochrane Library, Issue 1, 2002.

Statins for the prevention of Alzheimer's disease (Cochrane Review). Statine zur Prävention der Alzheimer-Krankheit (Cochrane Review). Scott HD, Laake K. The Cochrane Library, Issue 1, 2002. Scott HD, Laake K. The Cochrane Library, Issue 1, 2002.

Please note that NHS Direct is not responsible for the content of external websites. Bitte beachten Sie, dass NHS Direct ist nicht verantwortlich für die Inhalte externer Websites.